Both authors state that the manuscript has not been published elsewhere.
The upper bound to the Relative Reporting Ratio—a measure of the impact of the violation of hidden assumptions underlying some disproportionality methods used in signal detection
Version of Record online: 3 JAN 2014
© 2014 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Pharmacoepidemiology and Drug Safety
Volume 23, Issue 8, pages 787–794, August 2014
How to Cite
2014), The upper bound to the Relative Reporting Ratio—a measure of the impact of the violation of hidden assumptions underlying some disproportionality methods used in signal detection, Pharmacoepidemiol Drug Saf, 23: 787–794. DOI: 10.1002/pds.3556, and (
- Issue online: 28 JUL 2014
- Version of Record online: 3 JAN 2014
- Manuscript Accepted: 5 NOV 2013
- Manuscript Revised: 31 OCT 2013
- Manuscript Received: 24 SEP 2013
- 2Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 1999; 53: 177–190..
- 10Statistical methods for knowledge discovery in adverse drug reaction surveillance, Matematiska Institutionen 2007, http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6764 (last accessed on 28 September 2012)..
- 12Data mining in drug safety – review of published threshold criteria for defining signals of disproportionate reporting, Pharmaceut Med 2010; 24 (1): 37–43..
- 13Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst 1959; 22 (4): 718–749., .
- 15Optimization of a quantitative signal detection algorithm for spontaneous reports of adverse events post immunization. Pharmacoepidemiol Drug Saf 2012. DOI: 10.1002/pds.3392..